Amy DuRoss

Amy DuRoss General Information

Biography

Ms. Amy DuRoss serves as Board Member at Biolife Solutions. She Co-Founded and served as chief executive officer at Vineti. a healthcare technology company, since co-founding Vineti in April 2016. She serves as a Senior Advisor at Frazier Healthcare Partners. She has led Vineti and its software as a service platform to the forefront of innovation supporting cell and gene therapy manufacturing, delivery, and patient follow-up. Before co-founding Vineti, she focused on healthcare new business creation for GE Ventures, a venture capital subsidiary of General Electric (NYSE: GE), serving as a managing director from May 2013 to May 2017. Prior to GE, she was a chief business officer at Navigenics, Inc., a genomics company sold to Life Technologies Corporation in 2012. She was co-founder and executive director of Proposition 71, California's stem cell research initiative passed in 2004, as well as chief of staff at the resulting state grant oversight agency. She was named a 2016 Health Innovator Fellow by the Aspen Institute. She also serves as a member of the board of directors for the ARM Foundation for Cell and Gene Medicine. She holds an MBA, a Masters's degree in English, and a Bachelor of Arts degree in English from Stanford University.